JOURNAL CLUB: Women in Interventional Radiology: How Are We Doing?

Objective: This article describes survey findings as well as provides a narrative description of the issues facing women in interventional radiology (IR) today.

Materials And Methods: In an attempt to reflect the experiences of as many women interventional radiologists as possible, a survey was conducted via a post on the Women in Interventional Radiology page of SIR Connect, the online members-only forum of the Society of Interventional Radiology (SIR). The survey consisted of 62 items, including demographics, marital and parental status, experiences in training, relationships with coworkers and patients, and details about career achievements and goals.

Thoracic duct embolization and disruption for treatment of chylous effusions: experience with 105 patients.

Purpose: To review the indications, technical approach, and clinical outcomes of thoracic duct embolization (TDE) and thoracic duct disruption (TDD) in patients with symptomatic chylous effusions.

Materials And Methods: A total of 105 patients who underwent 120 consecutive TDE/TDD procedures were retrospectively reviewed. Data including cause of effusion, procedural technique, and pre- and postprocedural effusion volume were analyzed.

Acute Pericardial Effusion during Endovascular Intervention for Superior Vena Cava Syndrome: Case Series and Review.

We describe three cases of acute pericardial effusion during endovascular treatment of superior vena cava (SVC) syndrome, one of which resulted in fatal pericardial tamponade. SVC syndrome results from impaired venous return from the head and upper extremities to the right atrium. Malignancy and catheter-induced SVC stenosis accounts for the majority of cases of SVC syndrome.

Uterine artery embolization and hysteroscopic resection to treat retained placenta accreta: A case report.

Retained placenta is a serious cause of postpartum hemorrhage. Compounding this problem is the rare finding of a retained placenta accreta. Different authors have presented management options for retained placenta accreta that include methotrexate, uterine artery embolization, dilation and curettage, hysteroscopic loop resection, and hysterectomy.